Trial Profile
Phase I Randomized,Double-Blind,Placebo-controlled Trial in Healthy Male Voluteers To Examine the Safety,Tolerability,and Pharmacokinetics of HMPL-011 After A Single Dose.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Jul 2019
Price :
$35
*
At a glance
- Drugs HMPL 011 (Primary)
- Indications Inflammation; Multiple sclerosis; Rheumatoid arthritis
- Focus Pharmacokinetics
- Sponsors Hutchison MediPharma
- 25 Jul 2011 Status changed from not yet recruiting to completed.
- 20 Oct 2009 New trial record